Review
Open access
Jul 2026
The Past, Present, and Future of PSMA-Targeted Therapies in Prostate Cancer
The clinical and biological insights that have guided successive generations of PSMA-targeted therapeutic design are traced and the combination strategies and molecular profiling tools that will be essential for extending durable benefit across the broader mCRPC population are discussed.
Jasmine A. Anderson, Hao-Long Li
· Serican Journal of Medicine · 0 citations